GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Ovid Technologies (Wolters Kluwer Health)  (2)
Material
Publisher
  • Ovid Technologies (Wolters Kluwer Health)  (2)
Language
Years
  • 1
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2015
    In:  Circulation Vol. 131, No. suppl_1 ( 2015-03-10)
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 131, No. suppl_1 ( 2015-03-10)
    Abstract: Objective: We examined whether there were ethnic differences in glycosylated haemoglobin concentrations, the glycation gap and haemoglobin glycation index in non-diabetic adults. Research design and methods: We studied 3,318 non-diabetic adults aged 35 to 74 years. Glycoslylated haemoglobin (HbA1c) levels were compared in 1,589 Europeans, 825 Maori, 689 Pacific and 226 Asians. The glycation gap was calculated using the residuals from the regression of HbA1c on mean fasting and 2 hour glucose levels and the haemoglobin glycation index using the residuals from the regression of HbA1c on fructosamine. Results: Mean ± SD HbA1c was 38.0 ± 4.57 mmol/mol. After adjusting for age and gender, mean (se) HbA1c was higher in Maori (38.6 mmol/mol (0.14)), Pacific (40.8 (0.16)) and Asians (37.9 (0.27)) compared with Europeans (36.5 (0.10)) (all P & lt 0.0001 vs. Europeans). In contrast, there was little difference in fructosamine levels between ethnic groups with 231.5 (0.63) μmol/L in Europeans, 230.7 (0.44) in Maori, 237.8 (1.16) in Asians (both P & gt 0.05 versus Europeans), and 232.7 (0.16) in Pacific (P & lt 0.05). After adjusting for age, sex, education, body mass index (BMI), systolic and diastolic blood pressure, fasting and post-glucose load glucose levels, cholesterol, triglycerides, HDL-cholesterol, physical exercise levels, total calorie intake and socioeconomic status, HbA1c levels were 37.0 (0.10) mmol/mol in Europeans, and remained higher in Maori (38.4 (0.13)), Pacific (40.0 (0.15)) and Asians (38.1 (0.25)) (all P & lt 0.001) compared to Europeans. The mean (se) age and gender adjusted glycation gap (based on fructosamine) was -1.50 (0.10) mmol/mol for Europeans, 0.66 (0.14) mmol/mol for Maori, 2.77 (0.16) mmol/mol for Pacific (Both (P & lt 0.0001 vs. Europeans), and -0.37 (0.27) mmol/mol in Asians (P =0.001 vs. Europeans. Similarly, the mean haemoglobin glycation index (based on mean glucose) was -1.34 (0.10) in Europeans, 0.41 (0.13) in Maori, 2.63 (0.15) in Pacific (both P & lt 0.0001 versus Europeans) and -0.45 (0.25) in Asians (P = 0.001 vs. Europeans). Conclusion: There were differences in HbA1c, the glycation gap and the haemoglobin glycation index between Europeans and Maori, Pacific and Asian non-diabetic adults, but there was little difference between ethnic groups for fructosamine. These differences could be due to heritable factors that may vary between the ethnic groups or may be related to high or low glycators.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2015
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2016
    In:  Circulation Vol. 133, No. suppl_1 ( 2016-03)
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 133, No. suppl_1 ( 2016-03)
    Abstract: Introduction: We compared the utility of glycated hemoglobin (HbA1c) and oral glucose tolerance (oGTT) in non-diabetic patients for identifying incident diabetes, all-cause mortality, cardiovascular disease (CVD) mortality, all-CVD events, coronary heart disease (CHD) events, ischaemic stroke events and diabetes microvascular complications. Hypothesis: HbA1c will provide the similar information to an oGTT. Methods: Data from a New Zealand community setting were prospectively linked to hospitalization, mortality, pharmaceutical and laboratory test results data. After applying exclusion criteria (prior laboratory diagnosis or history of drug treatment for diabetes or hospitalisation for diabetes or CVD event), there were 31,148 adults who had an HbA1c and 2-hr 75g oGTT. HbA1c was measured by ion-exchange high-performance liquid chromatography, and glucose using a commercial enzymatic method. We compared glycaemic measures and outcomes using multivariable Cox proportional hazards regression. Results: The median follow-up time was 4 years (range 0 to 13). The mean age was 57.6 years and 53.0% were male. After adjusting for other glycaemic measures (fasting glucose, 2-hr glucose and/or HbA1c where relevant) in addition to age, sex and ethnicity, the hazard ratios for incident diabetes, and diabetes complications of retinopathy, nephropathy and neuropathy were highest for 2-hr postchallenge glucose levels, followed by HbA1c and lastly by fasting plasma glucose. However, all-cause mortality was significantly associated with HbA1c concentrations only. CHD events were most strongly associated with HbA1c, followed by 2-hr glucose and circulatory complications showed stronger associations with HbA1c. Conclusion: HbA1c showed stronger associations with adverse outcomes compared to fasting glucose and provides a convenient alternative to an oGTT.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2016
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...